Our top pick for
Building a portfolio
ImmunoPrecise Antibodies Ltd is a biotechnology business based in the US. ImmunoPrecise Antibodies shares (IPA) are listed on the NASDAQ and all prices are listed in US Dollars.
|52-week range||USD$0.4701 - USD$33.34|
|50-day moving average||USD$13.2126|
|200-day moving average||USD$14.1872|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Gross profit TTM||USD$8 million|
|Return on assets TTM||-9.68%|
|Return on equity TTM||-13.93%|
|Market capitalisation||USD$189.6 million|
TTM: trailing 12 months
There are currently 13,285 ImmunoPrecise Antibodies shares held short by investors – that's known as ImmunoPrecise Antibodies's "short interest". This figure is 20.1% down from 16,632 last month.
There are a few different ways that this level of interest in shorting ImmunoPrecise Antibodies shares can be evaluated.
ImmunoPrecise Antibodies's "short interest ratio" (SIR) is the quantity of ImmunoPrecise Antibodies shares currently shorted divided by the average quantity of ImmunoPrecise Antibodies shares traded daily (recently around 147611.11111111). ImmunoPrecise Antibodies's SIR currently stands at 0.09. In other words for every 100,000 ImmunoPrecise Antibodies shares traded daily on the market, roughly 90 shares are currently held short.
To gain some more context, you can compare ImmunoPrecise Antibodies's short interest ratio against those of similar companies.
However ImmunoPrecise Antibodies's short interest can also be evaluated against the total number of ImmunoPrecise Antibodies shares, or, against the total number of tradable ImmunoPrecise Antibodies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ImmunoPrecise Antibodies's short interest could be expressed as 0% of the outstanding shares (for every 100,000 ImmunoPrecise Antibodies shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable ImmunoPrecise Antibodies shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ImmunoPrecise Antibodies.
Find out more about how you can short ImmunoPrecise Antibodies stock.
We're not expecting ImmunoPrecise Antibodies to pay a dividend over the next 12 months.
You may also wish to consider:
ImmunoPrecise Antibodies's shares were split on a 4:1 basis on 29 May 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your ImmunoPrecise Antibodies shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for ImmunoPrecise Antibodies shares which in turn could have impacted ImmunoPrecise Antibodies's share price.
Over the last 12 months, ImmunoPrecise Antibodies's shares have ranged in value from as little as $0.4701 up to $33.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ImmunoPrecise Antibodies's is 0.0074. This would suggest that ImmunoPrecise Antibodies's shares are less volatile than average (for this exchange).
To put ImmunoPrecise Antibodies's beta into context you can compare it against those of similar companies.
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in the antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune and naive phage display production and screening; hybridoma production with screening and clone-picking; transgenic animals and multi-species antibody discovery; antibody characterization studies, such as affinity measurements, functional assays and epitope mapping, and binning; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA synthesis and cloning, protein and antibody downstream processing; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; and cryopreservation. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.
Steps to owning and managing PNRG, with 24-hour and historical pricing before you buy.
Steps to owning and managing PINC, with 24-hour and historical pricing before you buy.
Steps to owning and managing POAI, with 24-hour and historical pricing before you buy.
Steps to owning and managing PBTS, with 24-hour and historical pricing before you buy.
Steps to owning and managing PTMN, with 24-hour and historical pricing before you buy.
Steps to owning and managing BPOP, with 24-hour and historical pricing before you buy.
Steps to owning and managing PLYA, with 24-hour and historical pricing before you buy.
Steps to owning and managing PAGP, with 24-hour and historical pricing before you buy.
Steps to owning and managing PAA, with 24-hour and historical pricing before you buy.
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.